Vanda Pharmaceuticals Inc. 4
4 · Vanda Pharmaceuticals Inc. · Filed Jan 5, 2017
Insider Transaction Report
Form 4
Reverberi Gian Piero
SVP, General Manager Europe
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-01-03+7,500→ 22,500 total→ Common Stock (7,500 underlying) - Exercise/Conversion
Restricted Stock Unit
2017-01-03+12,500→ 37,500 total→ Common Stock (12,500 underlying) - Exercise/Conversion
Common Stock
2017-01-03+12,500→ 12,500 total - Exercise/Conversion
Common Stock
2017-01-03+7,500→ 20,000 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
- [F2]The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- [F3]Not Applicable.